A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256. (Q36379230)
Jump to navigation
Jump to search
scientific article published on 27 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256. |
scientific article published on 27 June 2012 |
Statements
1 reference
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256. (English)
1 reference
Timothy J Wilkin
1 reference
Christina M Lalama
1 reference
John McKinnon
1 reference
Rajesh T Gandhi
1 reference
Nina Lin
1 reference
Alan Landay
1 reference
Heather Ribaudo
1 reference
Lawrence Fox
1 reference
Judith S Currier
1 reference
John W Mellors
1 reference
Roy Gulick
1 reference
Allan R Tenorio
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference